Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Express Scripts
Chinese Patent Office
Novartis
McKesson
UBS
Federal Trade Commission
Accenture
Cerilliant
McKinsey

Generated: January 20, 2018

DrugPatentWatch Database Preview

ALINIA Drug Profile

« Back to Dashboard

When do Alinia patents expire, and when can generic versions of Alinia launch?

Alinia is a drug marketed by Romark and is included in two NDAs. There are three patents protecting this drug.

This drug has one hundred and thirty-one patent family members in forty-two countries.

The generic ingredient in ALINIA is nitazoxanide. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the nitazoxanide profile page.
Summary for ALINIA
Drug patent expirations by year for ALINIA
Pharmacology for ALINIA
Drug ClassAntiprotozoal

US Patents and Regulatory Information for ALINIA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Romark ALINIA nitazoxanide FOR SUSPENSION;ORAL 021498-001 Nov 22, 2002 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Romark ALINIA nitazoxanide TABLET;ORAL 021497-001 Jul 21, 2004 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Romark ALINIA nitazoxanide FOR SUSPENSION;ORAL 021498-001 Nov 22, 2002 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Romark ALINIA nitazoxanide FOR SUSPENSION;ORAL 021498-001 Nov 22, 2002 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ALINIA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Romark ALINIA nitazoxanide FOR SUSPENSION;ORAL 021498-001 Nov 22, 2002 ➤ Subscribe ➤ Subscribe
Romark ALINIA nitazoxanide FOR SUSPENSION;ORAL 021498-001 Nov 22, 2002 ➤ Subscribe ➤ Subscribe
Romark ALINIA nitazoxanide FOR SUSPENSION;ORAL 021498-001 Nov 22, 2002 ➤ Subscribe ➤ Subscribe
Romark ALINIA nitazoxanide TABLET;ORAL 021497-001 Jul 21, 2004 ➤ Subscribe ➤ Subscribe
Romark ALINIA nitazoxanide TABLET;ORAL 021497-001 Jul 21, 2004 ➤ Subscribe ➤ Subscribe
Romark ALINIA nitazoxanide TABLET;ORAL 021497-001 Jul 21, 2004 ➤ Subscribe ➤ Subscribe
Romark ALINIA nitazoxanide FOR SUSPENSION;ORAL 021498-001 Nov 22, 2002 ➤ Subscribe ➤ Subscribe
Romark ALINIA nitazoxanide FOR SUSPENSION;ORAL 021498-001 Nov 22, 2002 ➤ Subscribe ➤ Subscribe
Romark ALINIA nitazoxanide FOR SUSPENSION;ORAL 021498-001 Nov 22, 2002 ➤ Subscribe ➤ Subscribe
Romark ALINIA nitazoxanide FOR SUSPENSION;ORAL 021498-001 Nov 22, 2002 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for ALINIA

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,886,013 Antiviral composition ➤ Subscribe
5,387,598 Composition and galenic formulation suitable for combatting affections of the lower abdomen ➤ Subscribe
5,578,621 Benzamide derivatives ➤ Subscribe
6,020,353 2-(hydroxy)-N-(5-nitro-2-thiazolyl) benzamide ➤ Subscribe
5,859,038 Method for treatment of helicobacter pylori infections ➤ Subscribe
5,856,348 Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide ➤ Subscribe
6,051,576 Means to achieve sustained release of synergistic drugs by conjugation ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for ALINIA

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Deloitte
Teva
Daiichi Sankyo
Johnson and Johnson
UBS
Harvard Business School
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot